KPTA vows to protect domestic pharmaceutical industry

"We will have to resort to a lawsuit to fend off the government's new drug pricing policy that will shake up the domestic pharmaceutical industry, the Korea Pharmaceutical Manufacturers Association (KPMA) said in a statement.

The KPMA said the majority of domestic pharmaceutical firms cannot be viable under the so-called positive list system, adding that the domestic pharmaceutical industry ...